Menopause. Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with menopause
Conditions
Interventions
Treatment - Drugs
Control group: 3 milligram tablets of placebo of melatonin every night between 6 and 9 P.M. for 3 month
Sponsors
Vice chancellery of research,Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria of the study: having general health based on the Goldberg’s questionnaire (achieving score less than 23); married women between 40 to 60 years old; not using vitamin supplements; not having used hormone therapy during the last 3 months; complete physical health in physical examinations; cessation of the menstrual cycle for at least 6 months; and FSH above 40 IU. The exclusion criteria of the study: A history of active liver, kidney, heart, thyroid, diabetes and inflammatory diseases; inability to continue drug use for any reason; unwillingness to continue participation in the study; and showing allergic reaction to the drug. In addition, if any of the conditions listed in the inclusion criteria were violated at any time, the volunteer would be excluded from the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum lipid. Timepoint: Before intervention,3 month after intervention. Method of measurement: Lipid of plasma were measured based on the international units. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in body mass index. Timepoint: Before intervention,3 month after intervention. Method of measurement: Dividing weight in kilograms by the square of height in meters. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhadijeh Abdali
Shiraz University of Medical Sciences
Outcome results
None listed